Berchuck A - Search Results

1

Role of BRCA1 mutation screening in the management of familial ovarian cancer.

Berchuck A, Cirisano F, Lancaster JM, Schildkraut JM, Wiseman RW, Futreal A, Marks JR. Berchuck A, et al. Am J Obstet Gynecol. 1996 Sep;175(3 Pt 1):738-46. doi: 10.1053/ob.1996.v175.a74288. Am J Obstet Gynecol. 1996. PMID: 8828444 Review.

2

Comprehensive restaging laparotomy in women with apparent early ovarian carcinoma.

Soper JT, Johnson P, Johnson V, Berchuck A, Clarke-Pearson DL. Soper JT, et al. Among authors: berchuck a. Obstet Gynecol. 1992 Dec;80(6):949-53. Obstet Gynecol. 1992. PMID: 1333065

3

The effect of interferon gamma on epidermal growth factor receptor expression in normal and malignant ovarian epithelial cells.

Boente MP, Berchuck A, Rodriguez GC, Davidoff A, Whitaker R, Xu FJ, Marks J, Clarke-Pearson DL, Bast RC Jr. Boente MP, et al. Among authors: berchuck a. Am J Obstet Gynecol. 1992 Dec;167(6):1877-82. doi: 10.1016/0002-9378(92)91790-h. Am J Obstet Gynecol. 1992. PMID: 1361720

4

Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation.

Jacobs IJ, Kohler MF, Wiseman RW, Marks JR, Whitaker R, Kerns BA, Humphrey P, Berchuck A, Ponder BA, Bast RC Jr. Jacobs IJ, et al. Among authors: berchuck a. J Natl Cancer Inst. 1992 Dec 2;84(23):1793-8. doi: 10.1093/jnci/84.23.1793. J Natl Cancer Inst. 1992. PMID: 1433368

5

Radical hysterectomy in obese women.

Soisson AP, Soper JT, Berchuck A, Dodge R, Clarke-Pearson D. Soisson AP, et al. Among authors: berchuck a. Obstet Gynecol. 1992 Dec;80(6):940-3. Obstet Gynecol. 1992. PMID: 1448264

6

Oncogenes in ovarian cancer.

Berchuck A, Kohler MF, Bast RC Jr. Berchuck A, et al. Hematol Oncol Clin North Am. 1992 Aug;6(4):813-27. Hematol Oncol Clin North Am. 1992. PMID: 1500387 Review.

7

Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-beta.

Berchuck A, Rodriguez G, Olt G, Whitaker R, Boente MP, Arrick BA, Clarke-Pearson DL, Bast RC Jr. Berchuck A, et al. Am J Obstet Gynecol. 1992 Feb;166(2):676-84. doi: 10.1016/0002-9378(92)91697-9. Am J Obstet Gynecol. 1992. PMID: 1536252

8

Overexpression and mutation of p53 in endometrial carcinoma.

Kohler MF, Berchuck A, Davidoff AM, Humphrey PA, Dodge RK, Iglehart JD, Soper JT, Clarke-Pearson DL, Bast RC Jr, Marks JR. Kohler MF, et al. Among authors: berchuck a. Cancer Res. 1992 Mar 15;52(6):1622-7. Cancer Res. 1992. PMID: 1540970

9

The use of tumor markers in the management of patients with gynecologic carcinomas.

Berchuck A, Boente MP, Bast RC Jr. Berchuck A, et al. Clin Obstet Gynecol. 1992 Mar;35(1):45-54. doi: 10.1097/00003081-199203000-00009. Clin Obstet Gynecol. 1992. PMID: 1544249 Review. No abstract available.

10

Adjuvant therapy with intraperitoneal chromic phosphate (32P) in women with early ovarian carcinoma after comprehensive surgical staging.

Soper JT, Berchuck A, Dodge R, Clarke-Pearson DL. Soper JT, et al. Among authors: berchuck a. Obstet Gynecol. 1992 Jun;79(6):993-7. Obstet Gynecol. 1992. PMID: 1579329

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

641 results

Search Page

Filters